IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: IGF1 is believed to influence ageing and development of cardiovascular disease (CVD) through complex mechanisms. Reduced IGF1 levels might be causally associated with conditions accompanying ageing including development of CVD. However, in animal models reduced GH–IGF1 signalling increases lifespan. Reduced IGF1 activity might also be associated with longevity in humans. Objective: The objective was to investigate if plasma IGF1 levels were associated with all cause mortality, and the development of chronic heart failure (CHF) and a major CV event. Patients and design: A population based study of 642 individuals, aged 50–89 years. Development of CHF was evaluated in 576 individuals with normal systolic function assessed by echocardiography and without the history of CHF or myocardial infarction. Development of the first major CV event was evaluated in 504 individuals with normal systolic function and without prevalent CVD. Outcomes were ascertained after 5 years using hospital discharge diagnoses. Results: Adjustment for risk factors IGF1 values in the fourth quartile versus values below the fourth quartile was associated with increased mortality ( n =103), hazard ratio (HR) 1.52 (95% confidence interval (CI) 1.01–2.28; P =0.044). IGF1 in the fourth quartile was also independently associated with risk of development of CHF ( n =19), HR 5.02 (95% CI 2.00–12.64; P =0.001) but showed no association with the overall incidence of major CV events ( n =58), HR 1.05 (95% CI 0.59–1.90; P =0.861). Conclusions: High IGF1 levels were independently associated with increased all cause mortality and risk of development of CHF, whereas no relation with the overall incidence of CVD was observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“Furthermore, increased mortality has been suggested in GHD caused by various pituitary diseases ( 13 ).”
BackgroundFunctionally significant insulin-like growth factor I receptor mutations in centenarians
Suh, Y., Atzmon, G., Cho, M.-O., Hwang, D., Liu, B., Leahy, D. J., Barzilai, N., & Cohen, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705467105 · Cited by 703 · cited 2×
“... of GHD on mortality in hypopituitarism is subject to debate and the influence of confounding factors as suboptimal replacement therapy and cranial radiation has not been clarified (27) .A recent published study on centenarians and a review addressing lifespan in Laron syndrome (primary GH resistance) have suggeste…”
BackgroundJuul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Kistorp, C. (2005) · JAMA · doi:10.1001/jama.293.13.1609 · Cited by 535
Self-citationLaughlin, G. A., Barrett-Connor, E., Criqui, M. H., & Kritz-Silverstein, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030967 · Cited by 374 · cited 1×
“The authors concluded that the side effects outweigh beneficial effects mainly due to soft tissue oedema, arthralgias and insulin resistance (28) .B y contrast to our results, two previous published studies in American background populations have not found any influence of IGF1 levels on all cause mortality ( 8 , 29)…”
ResultSystematic review: the safety and efficacy of growth hormone in the healthy elderly
Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00005 · Cited by 370 · cited 2×
“The authors concluded that the side effects outweigh beneficial effects mainly due to soft tissue oedema, arthralgias and insulin resistance ( 28 ) .B y contrast to our results, two previous published studies in American background populations have not found any influence of IGF1 levels on all cause mortality (8, 29)…”
ResultThe GH-IGF1 axis and longevity: the paradigm of IGF1 deficiency
Laron, Z. (2008) · HORMONES · doi:10.14310/horm.2002.1111034 · Cited by 80
Insulin-like growth factors and subsequent risk of mortality in the United States
Saydah, S., Graubard, B., Ballard-Barbash, R., & Berrigan, D. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm124 · Cited by 71 · cited 1×
“The authors concluded that the side effects outweigh beneficial effects mainly due to soft tissue oedema, arthralgias and insulin resistance (28) .B y contrast to our results, two previous published studies in American background populations have not found any influence of IGF1 levels on all cause mortality (8, 29 ) .…”
Result
Cited by
Justice, J. N., Ferrucci, L., Newman, A. B., Aroda, V. R., Bahnson, J. L., Divers, J., Espeland, M. A., Marcovina, S., Pollak, M. N., Kritchevsky, S. B., et al. (2018) · GeroScience · doi:10.1007/s11357-018-0042-y · Cited by 359
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Milman, S., Huffman, D. M., & Barzilai, N. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.014 · Cited by 150
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Genetics of human longevity within an eco-evolutionary nature-nurture framework
Giuliani, C., Garagnani, P., & Franceschi, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312562 · Cited by 92
Metadata
- Authors
- Andreassen, M., Raymond, I., Kistorp, C., Hildebrandt, P., Faber, J., & Kristensen, L. Ø.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01
- Volume
- 160
- Issue
- 1
- Pages
- 25-31
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2134441573
- Cited by
- 123
- References
- 8
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. https://app.cochat.ai/papers/10.1530/eje-08-0452
- The paper
- Andreassen, M., Raymond, I., Kistorp, C., Hildebrandt, P., Faber, J., & Kristensen, L. Ø. (2009). IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. European Journal of Endocrinology. https://doi.org/10.1530/eje-08-0452
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.